Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001013762-23-004162
Filing Date
2023-10-16
Accepted
2023-10-16 17:18:12
Documents
4
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT pre14a1023_pasithea.htm PRE 14A 1658020
2 GRAPHIC tlogo.jpg GRAPHIC 102835
3 GRAPHIC tproxy_001.jpg GRAPHIC 1253444
4 GRAPHIC tproxy_002.jpg GRAPHIC 855264
  Complete submission text file 0001013762-23-004162.txt   4705788
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40804 | Film No.: 231327991
SIC: 2834 Pharmaceutical Preparations